To characterize the role of DPP-4 in the metabolism of AIS patients, Normand et al. [14] firstly isolated osteoblast from AIS patients and controls and reported abnormally down-regulated expression of DPP-4 in AIS patients. Here, DPP4 is linked to androgen insensitivity syndrome.